���他鲁肽开发背景 — Reference Sheet

By Editorial Desk · published 2025-08-27 · last reviewed 2025-09-21 · Topic

peptide backbone comes up often in conversation and rarely with the context attached. Here we lay out the basics in order, then work through the practical considerations.

Updated 2025-09-21. Numbers and descriptions here follow the published literature rather than marketing material.

瑞他鲁肽开发背景

开发进程从早期单次和多次给药研究推进至大规模后期试验。公开报告显示，参与者在体重和相关代谢指标上出现变化，但完整数据需经同行评审并接受独立复核。试验设计通常包括随机、双盲和对照设置，以区分药物效应与行为干预。监管提交和标签范围尚未确定；长期维持效果与心血管结局仍是开放问题。

与仅靶向单一受体的同类药物相比，瑞他鲁肽增加胰高血糖素受体成分，理论上可提高能量消耗并改变脂肪分布。临床中观察到的体重变化是否主要来自该额外机制，目前尚无定论。胃肠道反应是该类药物常见不良事件，试验中通过剂量递增和监测进行管理。停药后体重反弹、个体差异和长期耐受性仍需更多数据。

瑞他鲁肽是一种在研合成肽，同时作用于胰高血糖素样肽-1、葡萄糖依赖性促胰岛素多肽和胰高血糖素受体。该分子属于多受体激动剂类别，尚未获得任何监管机构的上市批准。当前临床开发主要针对肥胖和2型糖尿病，研究代号为LY3437943。已确立的信息包括受体靶点和部分中期试验结果；最终疗效、长期安全性和适用人群仍属开放问题。

Peptide Identity and Receptor Targets

Development has progressed from single- and multiple-ascending-dose studies in healthy volunteers into larger randomized trials in adults with obesity, type 2 diabetes, and fatty liver disease. Early reports describe dose-dependent reductions in body weight and improvements in glycemic markers over treatment periods of several months. Whether the glucagon arm adds tolerability cost without added benefit is still debated. Long-term cardiovascular outcomes, effects after treatment stops, and performance in older or comorbid populations are open questions rather than settled findings. Approval status may change, so the current investigational label should be confirmed against regulatory sources.

Retatrutide is an investigational synthetic peptide developed under the code LY3437943, with a backbone derived from glucose-dependent insulinotropic polypeptide. Several non-proteinogenic residues, including alpha-aminoisobutyric acid, appear in that backbone, and a fatty diacid side chain attached through a linker extends circulation time. The molecule carries roughly thirty-nine amino acid units and a total mass near 4.7 kilodaltons. Administration is by subcutaneous injection once weekly. Published work uses both the name retatrutide and the code LY3437943.

Pharmacologically the compound activates three receptors: GLP-1, GIP, and glucagon. GLP-1 and GIP signaling contribute to glucose-dependent insulin release, delayed gastric emptying, and reduced appetite, while glucagon receptor activation is associated with increased energy expenditure and hepatic fat oxidation. The single-molecule design is intended to keep these activities in one peptide rather than combining separate agents. Relative activity at each receptor differs, and the balance between them is a central question in interpretation. The glucagon component is partly offset by incretin-mediated insulin secretion, an interaction that remains incompletely characterized.

Retatrutide at a glance

Background and Receptor Pharmacology

The three-receptor design places retatrutide in a distinct category relative to older incretin-based therapies. Single agonists target one receptor, and dual agonists target two. Adding a third target broadens the pharmacological footprint and introduces new trade-offs among efficacy, tolerability, and glucose control. How these trade-offs resolve in large trials is a central focus of current research.

Retatrutide is an investigational peptide studied for obesity and type 2 diabetes. It is a single synthetic molecule designed to activate three metabolic receptors simultaneously. The compound belongs to the incretin mimetic family, a group of peptides that imitate gut hormones involved in appetite and glucose control. Its research code is LY3437943, and it remains under clinical study rather than cleared for routine medical use.

Related pages on this site

• Standard index
• Practical dataset
• Modular handbook
• Regional playbook
• Seasonal digest
• Quality index
• Tracked playbook
• Clear checklist

Molecular Identity and Receptor Targets

Retatrutide is a synthetic peptide developed as a single molecule that activates three distinct hormone receptors: GLP-1, GIP, and glucagon. The compound carries the internal designation LY3437943 and was engineered by modifying the backbone of glucose-dependent insulinotropic polypeptide. Its sequence incorporates non-natural amino acids and a fatty acid side chain that extends circulation time. The triple-agonist design aims to combine appetite suppression, improved insulin response, and increased energy expenditure in one agent. Published reports describe it as an investigational product rather than an approved medicine.

Each receptor contributes a different physiological effect. Activation of the GLP-1 receptor slows gastric emptying and reduces appetite signaling in the brain. GIP receptor activity influences insulin secretion and lipid handling, while glucagon receptor stimulation raises energy use and fat oxidation. Combining these pathways is intended to produce weight loss beyond what single- or dual-receptor agonists achieve. Researchers attribute the observed potency to simultaneous engagement of all three targets, though the exact contribution of each receptor to overall effect remains under investigation.

Discovery and Triple Receptor Pharmacology

Receptor activation produces downstream effects that differ by tissue. GLP-1 receptor signaling influences appetite regulation and insulin secretion in a glucose-dependent manner. GIP receptor activity contributes to metabolic handling of nutrients and may modulate adipose tissue. Glucagon receptor engagement raises energy expenditure and promotes hepatic lipid turnover, though the balance among these actions in humans is still being characterized. Preclinical models showed reductions in body weight and improved glycemic markers.

Clinical development has progressed through phase 2 trials in adults with obesity and type 2 diabetes, with phase 3 programs reported as ongoing. Reported outcomes include reductions in body weight and improvements in glycemic measures over defined treatment periods. Whether these effects translate into durable benefits after treatment ends remains an open question. Long-term safety data across broad populations are not yet complete, and regulatory decisions have not been announced.

Retatrutide is an investigational synthetic peptide engineered to activate three distinct hormone receptors within a single molecule. It targets the glucose-dependent insulinotropic polypeptide receptor, the glucagon-like peptide-1 receptor, and the glucagon receptor simultaneously. This triagonist design distinguishes it from earlier incretin-based compounds that act on one or two of these pathways. Structural modifications relative to native gut hormones extend its residence time in circulation. The molecule remains under clinical evaluation and is not approved for any indication.

Supporting material

=== Reconstitution === On 13 August 1976, Deputy Premier and Liberal leader Sir Gordon Chalk resigned, resulting in a reshuffle. William Knox replaced Chalk in his roles, while John Greenwood was appointed to the vacant position in the ministry. Keith Hooper, Minister for Transport and Liberal member for Greenslopes, died on 23 August 1977. Fred Campbell added Transport to his roles for the remainder of the parliamentary term.

== People with the name == Link (singer) (Lincoln Browder, born 1964), American R&B singer Link (surname) Charles Lincoln "Link" Neal III of Rhett & Link (born 1978), American comedian and YouTuber Link Wray (1929–2005), American rock-and-roll guitarist

== Catabolic hormones == There are many signals that control catabolism. Most of the known signals are hormones and the molecules involved in metabolism itself. Endocrinologists have traditionally classified many of the hormones as anabolic or catabolic, depending on which part of metabolism they stimulate. The so-called classic catabolic hormones known since the early 20th century are cortisol, glucagon, and adrenaline (and other catecholamines). In recent decades, many more hormones with at least some catabolic effects have been discovered, including cytokines, orexin (known as hypocretin), and melatonin.

transition, which has been considered for the creation of a transportable optical clock as all transitions necessary for clock operation can be addressed with direct diode lasers at common wavelengths. Some of the few practical uses of radium are derived from its radioactive properties. More recently discovered radioisotopes, such as cobalt-60 and caesium-137, are replacing radium in even these limited uses because several of these isotopes are more powerful emitters, safer to handle, and available in more concentrated form. The isotope 223Ra was approved by the United States Food and Drug Administration in 2013 for use in medicine as a cancer treatment of bone metastasis in the form of a solution including radium-223 chloride. The main indication of treatment is the therapy of bony metastases from castration-resistant prostate cancer. 225Ra has also been used in experiments concerning therapeutic irradiation, as it is the only reasonably long-lived radium isotope which does not have radon as one of its daughters. Radium was still used in 2007 as a radiation source in some industrial radiography devices to check for flawed metallic parts, similarly to X-ray imaging. When mixed with beryllium, radium acts as a neutron source. Up until at least 2004, radium-beryllium neutron sources were still sometimes used, but other materials such as polonium and americium have become more common for use in neutron sources. RaBeF4-based (α, n) neutron sources have been deprecated despite the high number of neutrons they emit (1.84×106 neutrons per second) in favour of 241Am–Be sources.

Methamphetamine (contracted from N-methyl-alpha-methylphenethylamine) is a potent stimulant of the phenethylamine and amphetamine classes that is used to treat attention deficit hyperactivity disorder (ADHD) and obesity. Methamphetamine exists as two enantiomers, dextrorotary and levorotary. Dextromethamphetamine is a stronger CNS stimulant than levomethamphetamine; however, both are addictive and produce the same toxicity symptoms at high doses. Although rarely prescribed due to the potential risks, methamphetamine hydrochloride is approved by the US Food and Drug Administration (FDA) under the trade name Desoxyn. Recreationally, methamphetamine is used to increase sexual desire, lift the mood, and increase energy, allowing some users to engage in sexual activity continuously for several days straight. Methamphetamine may be sold illicitly, either as pure dextromethamphetamine or in an equal parts mixture of the right- and left-handed molecules (i.e., 50% levomethamphetamine and 50% dextromethamphetamine). Both dextromethamphetamine and racemic methamphetamine are Schedule II controlled substances in the United States. Also, the production, distribution, sale, and possession of methamphetamine is restricted or illegal in many other countries due to its placement in Schedule II of the United Nations Convention on Psychotropic Substances treaty. In contrast, levomethamphetamine is an over-the-counter drug in the United States. In low doses, methamphetamine can cause an elevated mood and increase alertness, concentration, and energy in fatigued individuals.

Sources: en.wikipedia.org

Supporting material

Jack Straw (born 3 August 1946), Christian, of Eastern European Jewish ancestry; served in Cabinet under Labour governments of Tony Blair and Gordon Brown as Home Secretary and Foreign Secretary; has written for The Guardian, Daily Mail, El País, The Independent, The Mirror UK, The Sun, The Telegraph, Financial Times, The Times, POLITICO, LSE Connect, Prospect Magazine, The New European and is author or co-author of the following books; The English Job: Understanding Iran and Why It Distrusts Britain (2019) ISBN 978-1785903991; Implementation of the Human Rights Act 1998: Minutes of Evidence, Wednesday 14 March 2001 (2001) ISBN 0-10-442701-9; Making Prisons Work: Prison Reform Trust Annual Lecture (1998) ISBN 0-946209-44-8; Future of Policing and Criminal Justice (Institute of Police & Criminological Studies Occasional Paper S.) (1996) ISBN 1-86137-087-3 and Policy and Ideology (1993) ISBN 0-9521163-0-8 John Strawson, author of Encountering Islamic law, Partitioning Palestine: Legal Fundamentalism in the Palestinian-Israeli Conflict and editor of Law after Ground Zero and Tracking the Postcolonial in Law; also law professor at the University of East London School of Law, teaching International law and Middle East Studies; specialises in law and postcolonialism, with particular reference to middle east, Islam and international law; previous posts include visiting positions at Birzeit University (Palestine) and the Institute of Social Studies (The Hague Netherlands); researches encounter between western and Islamic law; is Director of Law Postgraduate Programmes at University of East London, and Director of the Centre on Human Rights in Conflict; believes use of term apartheid to describe Israel or Israeli policies does not apply to Israel, and use of analogy is unhistorical, and unhelpful. Jamie Susskind (b. 1989); barrister and author of Oxford University Press books on Marxism, freedoms, democracy and technology; was appointed as a research fellow at Harvard's Berkman Klein Center for Internet and Society; practises law at Littleton Chambers; his book Future Politics: Living Together in a World Transformed by Tech, listed by London School of Economics as one of top ten books of 2019; book approaches issues of technological change in political arena from legal standpoint, speculating on various ways technology would change interactions between citizens and political process; was awarded Book of the Year by Evening Standard and Prospect Magazine, Book of the Day by The Guardian and received the 2019 Estoril Global Issues Distinguished Book Prize; his book, The Digital Republic: On Freedom and Democracy in the 21st Century concerns dangers, problems, and solutions to Big Tech. Richard Susskind OBE FRSE (born 28 March 1961); author, speaker, independent adviser to international professional firms and national governments; IT adviser to Lord Chief Justice of England and Wales, holds professorships at the University of Oxford, Gresham College and Strathclyde University, is a past chair of Advisory Panel on Public Sector Information, and is president of the Society for Computers and Law; has authored nine books and is regular columnist at The Times. Adam Sutcliffe; Professor of European History at King's College London, journalist writing on Jewish history and identity for Times Literary Supplement, author of What Are Jews For: History, Peoplehood, and Purpose (Princeton University Press, 2020), Judaism and Enlightenment; coeditor of Philosemitism in History, The Cambridge History of Judaism: The Early Modern World, and History, Memory and Public Life: The Past in the Present. William Sutcliffe, novelist; New Boy (1986), Are You Experienced? (1997), Whatever Makes You Happy (2008), and The Wall (2013), set in an Israeli colony David Sylvester (21 September 1924 – 19 June 2001), prolific author, art critic, journalist and curator; trustee of the Tate Gallery; influential in promoting modern artists Francis Bacon, Joan Miró, and Lucian Freud; father of modern artist Cecily Brown; credited with coining the term Kitchen sink realism originally to describe a strand of post-war British painting. Mitchell Symons, writer Henri Tajfel (born Hersz Mordche; 22 June 1919 – 3 May 1982) was a Polish Jewish social psychologist and author, best known for his books and pioneering work on the cognitive aspects of prejudice and social identity theory, as well as being one of the founders of the European Association of Experimental Social Psychology. He also worked for the United Nations International Refugee Organization. Adam Thirlwell, FRSL (born 22 August 1978) is a British novelist. His work has been translated into thirty languages. He has twice been named as one of Granta's Best of Young British Novelists. In 2015 he received the E.M. Forster Award from the American Academy of Arts and Letters. He is an advisory editor of The Paris Review. Barbara Trapido (born 1941 as Barbara Schuddeboom), is a British novelist born in South Africa with German, Danish and Dutch ancestry. Born in Cape Town and growing up in Durban she studied at the University of Natal gaining a BA in 1963 before emigrating to London. After many years teaching, she became a full-time writer in 1970. Michael Tugendhat (born 21 October 1944),; retired High Court judge; was High Court's senior media judge; author and editor of The Law of Privacy and the Media Oxford University Press; Commercial Fraud: Civil Liability, Human Rights, and Money Laundering Oxford University Press; Les droits du genre humain : la liberté en France et en Angleterre (1159–1793), [The rights of mankind : liberty in France and England (1159–1793)] (with Elizabeth de Montlaur Martin, 2021), ISBN 978-2-36517-110-6, Société de Législation comparée, Paris (awarded by the French Académie des sciences morales et politiques the Prix Édouard Bonnefous 2022); Liberty Intact: Human Rights in English Law (2016) Oxford University Press and Fighting for Freedom? (2017), ISBN 978-1-911128-49-6, Bright Blue (organisation) Jackie Walker (activist), anti Zionist playwright, pro-Palestinian, anti fascist author, of Sephardi Jewish and Jamaican origin. Arthur Waley (1889–1966); orientalist and sinologist of Ashkenazi ancestry; renowned for his translations of Chinese and Japanese poetry; awarded the CBE in 1952, the Queen's Gold Medal for Poetry; invested as a Companion of Honour in 1956. Natasha Walter (born 20 January 1967), feminist writer, novelist, human rights activist, founder of charity Women for Refugee Women; father was Nicolas Walter, an anarchist and secular humanist writer; of German Jewish ancestry; journalist forVogue magazine; Deputy Literary Editor of The Independent; columnist and feature writer for The Guardian; appear regularly on BBC2's Newsnight Review and Radio 4's Front Row; was judge on the Booker Prize and was a judge on the Women's Prize for Fiction (formerly the Orange Prize); was the founder in 2006 of the charity Women for Refugee Women, where she was the director until 2021. The charity supports women who seek asylum to tell their stories and challenges injustices they experience. She was recognized as one of the BBC's 100 women of 2013. Nicolas Walter (22 November 1934 – 7 March 2000) was a British anarchist and atheist writer, speaker and activist. He was a member of the Committee of 100 and Spies for Peace, and wrote on topics of anarchism and humanism. Fredric Warburg (27 November 1898 – 25 May 1981), author, publicist, publisher best known for association with George Orwell. Besides his own work as an author, he promoted and published Franz Kafka. Other notable publications included The Third Eye by Lobsang Rampa, Adolf Hitler's Mein Kampf and William Shirer's The Rise and Fall of the Third Reich. Ruby Wax (née Wachs; born 19 April 1953) is an American-British actress, author of popular self-help books, comedian, television personality, and popular mental health campaigner, of Austrian Jewish descent; appointed Chancellor of the University of Southampton; Wax also teaches business communication in the public and private sectors. Clients include Deutsche Bank, the UK Home Office and Skype. Eyal Weizman (born 1970) is a British Israeli architect and author of over twenty books and academic papers, mostly on the Israeli occupation of Palestinian land and the architecture of the wall around Gaza. He is the director of the research agency Forensic Architecture at Goldsmiths, University of London where he is Professor of Spatial and Visual Cultures and a founding director there of the Centre for Research Architecture at the department of Visual Cultures. In 2019 he was elected Fellow of the British Academy. Rosie Whitehouse, journalist and author. Wife of Tim Judah and mother of Ben Judah; of Iraqi Jewish ancestry. Her historical research and profiles of Holocaust Survivors have been published by The Observer, The Jewish Chronicle, BBC News and Tablet magazine. Meanwhile, her writing about British government policy toward victims after the Holocaust and contemporary British antisemitism has appeared in The Independent and Haaretz. Stephen Winsten, (1893–1991) was the name adopted by Samuel Weinstein, one of the 'Whitechapel Boys' group of young Jewish men and future writers in London's East End in the years before World War I (the others included Isaac Rosenberg, John Rodker and Joseph Leftwich). In the First World War he was a conscientious objector, and imprisoned in Bedford and Reading gaols. He is now known for his works about George Bernard Shaw, and his writing on the life of Henry Salt. Robert Winston, Baron Winston (born 15 July 1940), British professor, author, journalist, medical doctor, scientist, television presenter and Labour Party politician.He is a member of Labour Friends of Israel; father of Ben Winston, renowned for producing a number of the annual Brit Awards from 2011 to 2014 and more recently he was a co-producer of US Grammy Awards and Tony Awards. Ludwig Wittgenstein (26 April 1889 – 29 April 1951) was an Austrian-Jewish British philosopher who worked primarily in logic, the philosophy of mathematics, the philosophy of mind, and the philosophy of language. He is considered by some to be the greatest philosopher of the 20th century. Richard Wollheim (5 May 1923 − 4 November 2003), prolific author noted for work on mind and emotions related to visual arts, specifically, painting; served as president of the British Society of Aesthetics; was Grote Professor of Mind and Logic, professor at Columbia University and University of California at Berkeley and lecturer at Balliol College, Harvard University, the University of Minnesota, Graduate Center, CUNY, the University of California at Davis; gave Andrew M. Mellon lectures in Fine Arts, National Gallery of Art, Washington; his book Art and its Objects considered one of the twentieth century's most influential texts on philosophical aesthetics; known for philosophical treatments of depth psychology, especially Sigmund Freud's Jonathan Wolff (born 1959) author of seven Oxford University Press academic books and numerous monographs and journals, philosopher and scholar; Professor of Values and Public Policy at the Blavatnik School of Government at the University of Oxford; Governing Body Fellow at Wolfson College; previously at University College London (UCL), where he was Professor of Philosophy and Dean of the Faculty of Arts and Humanities; was secretary of the British Philosophical Association and has been Editor and honorary secretary of the Aristotelian Society; presented a four-part series about the UK's National Health Service (NHS) for the BBC's Radio 3; was member of the Nuffield Council on Bioethics; was elected Fellow of the British Academy in 2023. Leonard Woolf, writer and activist Bat Ye'or (born 1933), best known for creating and popularising Eurabia conspiracy theory in her writings about modern Europe. Tamar Yellin (b. 1963), author whose first novel, The Genizah at the House of Shepher, won Sami Rohr Prize for Jewish Literature; granddaughter of Yitzhak Yaakov Yellin (1885–1964), pioneer of Hebrew language press in Palestine; Jane Yolen (February 11, 1939) is an American writer of fantasy and part-time resident in the UK, science fiction, and children's books. She is the author or editor of more than 400 books, of which the best known is The Devil's Arithmetic, a Holocaust novella Israel Zangwill (1864–1926), novelist and playwright. Zangwill was a British author at the forefront of cultural Zionism during the 19th century, and was associate of Theodor Herzl, later rejecting search for a Jewish homeland in Palestine. Father of Oliver Zangwill and husband of Suffragette Edith Ayrton. Theodore Zeldin, writer

== External links == Canadian Society of Clinical Chemists Canadian Academy of Clinical Biochemistry Canadian Laboratory Initiative on Paediatric Reference Intervals (CALIPER) The International Federation of Clinical Chemistry and Laboratory Medicine

== History == Octreotide acetate was approved for use in the United States in 1988. In January 2020, approval of octreotide acetate in the United States was granted to Sun Pharmaceutical under the brand name Bynfezia Pen for the treatment of:

is the fraction of receptor bound by the ligand. This expression is one way to consider the effect of a drug, in which the response is related to the fraction of bound receptors (see: Hill equation). The fraction of bound receptors is known as occupancy. The relationship between occupancy and pharmacological response is usually non-linear. This explains the so-called receptor reserve phenomenon i.e. the concentration producing 50% occupancy is typically higher than the concentration producing 50% of maximum response. More precisely, receptor reserve refers to a phenomenon whereby stimulation of only a fraction of the whole receptor population apparently elicits the maximal effect achievable in a particular tissue. The simplest interpretation of receptor reserve is that it is a model that states there are excess receptors on the cell surface than what is necessary for full effect. Taking a more sophisticated approach, receptor reserve is an integrative measure of the response-inducing capacity of an agonist (in some receptor models it is termed intrinsic efficacy or intrinsic activity) and of the signal amplification capacity of the corresponding receptor (and its downstream signaling pathways). Thus, the existence (and magnitude) of receptor reserve depends on the agonist (efficacy), tissue (signal amplification ability) and measured effect (pathways activated to cause signal amplification). As receptor reserve is very sensitive to agonist's intrinsic efficacy, it is usually defined only for full (high-efficacy) agonists.

Sources: en.wikipedia.org

Frequently asked questions